Stanford University’s seed grants support innovative, multidisciplinary research on pediatric IBD and celiac disease, with a special focus on advancing celiac disease research this cycle.
Funder: Stanford University
Due Dates: September 22, 2026 (Letter of Intent) | February 1, 2027 (Full Proposal by invitation)
Funding Amounts: Up to $100,000 per year for 2 years (total $200,000 per project)
Summary: Supports innovative, multidisciplinary research in pediatric IBD and celiac disease, with a special emphasis on advancing celiac disease research this cycle.
Key Information: Stanford faculty and Center membership required; multidisciplinary and celiac-focused proposals encouraged.
This internal Stanford University seed grant program aims to catalyze innovative and multidisciplinary research to advance the understanding, diagnosis, and treatment of pediatric inflammatory bowel disease (IBD) and celiac disease. The program is intended to support early-stage, high-risk, and high-reward projects that are not yet eligible for larger government funding. This year, there is a particular emphasis on projects focused on celiac disease, welcoming diverse scientific approaches from basic, translational, clinical, and computational research. Collaborative proposals, especially those bridging disciplines (e.g., basic/data scientists with physician scientists), are strongly encouraged.